Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Engiven: A Platform for CryptoCurrency Contributions

By Dana Blankenhorn, InvestorPlace Contributor

Engiven, founded by two evangelical church members in San Diego, hopes to unlock the power of blockchain to make non-profits more transparent and powerful.

Inovio Becomes a Covid-19 Longshot

By Dana Blankenhorn, InvestorPlace Contributor

No one knows which of the many vaccine candidates will be safe and effective, but Inovio's unique approach has left it without a major manufacturing contract.

It’s Too Late to Get In On Target Stock Despite Solid Earnings

By Dana Blankenhorn, InvestorPlace Contributor

A great quarter has Target stock trading well above fundamentals. It might be time to take profits and speculate elsewhere.

Novavax Is the Ultimate Coronavirus Stock

By Dana Blankenhorn, InvestorPlace Contributor

Novavax has failed at late-stage clinical trials before, but if its COVID-19 vaccine even has 50% efficacy it could open up a huge global opportunity.

Kohl’s Stock Has Reached the Retail Lifeboat

By Dana Blankenhorn, InvestorPlace Contributor

Kohl's will make it through the pandemic thanks to its digital savvy and off-mall locations. You should buy KSS stock now.

Sorrento Stock: Gambling on Coronavirus

By Dana Blankenhorn, InvestorPlace Contributor

Few companies are in all the major Covid-19 sectors, but Sorrento has made claims for a test, a vaccine and a cure. This brought many eyes to SRNE stock.

Once Slow, Stable Sanofi Stock is Now Pharma’s Most-Talked About Name

By Dana Blankenhorn, InvestorPlace Contributor

SNY stock is no longer a sleepy passive investment. Under a new CEO, Sanofi is less reliant on diabetes and heart drugs and looking to buy pre-market cancer blockbusters.

5 Election Stocks for a Biden Presidency

By Dana Blankenhorn, InvestorPlace Contributor

Biden supports renewable energy, manufacturers and a strong banking sector. That's why investors will want to watch these election stocks as November approaches.

Regeneron Stock Is a Play For Covid-19, And More

By Dana Blankenhorn, InvestorPlace Contributor

Regeneron is trialing a cocktail of antibodies that may treat Covid-19 and prevent illness for people routinely exposed.

Investors Should View IBIO Stock Among Vaccine Wanna-be’s, Not Makers

By Dana Blankenhorn, InvestorPlace Contributor

IBIO stock has been acting like a potential COVID-19 vaccine producer, but it lacks contracts with leading providers and its own work remains at a pre-clinical stage.

Load More